Eurostars #1: Praxa Sense’s AMBULAS project

Liselotte StolkSubsidies

Praxa Sense is proud to announce its success in the most recent Eurostars round, where we ranked number 1 out of all 428 applications in Europe. With the AMBULAS project we will further develop our sensor system, the most accurate remote monitoring device for continuous passive measurements in an ambulant environment of (among others) ECG, blood oxygen saturation, temperature and movement. The combination of these measurements are highly valued in remote monitoring in multiple care paths.  

During this project an additional revolutionary sensor will be developed that overcomes problems of inaccuracy due to motion sensitivity, one of the biggest obstacles in reliable remote monitoring. Thus, the device can provide relief to an overburdened healthcare system, while delivering regular and accurate readings that require minimal involvement from the patient. 

We are proud of our collaboration with Catalyze, AdviCo Microelectronics and Fraunhofer Institute for Microelectronic Circuits and Systems n the development of this top-of-class Eurostars proposal and look forward to the partnership with our new international partners. 

About Eurostars 

Eurostars is a European innovation program and an initiative of EUREKA and the European Commission. Eurostars provides financial support to projects through the national government of each participating country. Eurostars helps (small) companies to carry out market-oriented technological development. It aims to shorten the time-to-market of these new technologies and reduce technical risks. This allows small businesses to develop and grow faster.  

We are very happy that the The Ministry of Economic Affairs and Climate together with RVO make this funding available for innovative solutions like Afi. The funds will be used to further expand the possibilities of our medical device, which is now suitable for long term monitoring of arrhythmias, to be able to be used for the monitoring of Heart Failure patients. For this group there are currently not enough reliable solutions. This way we are one step closer in using technical innovations to change the lives of people who are less fortunate in their health. 

Looking forward to the future! 🍾